UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 302

Sortiert nach

A bone paradigm challenging the standard model of myeloma oncogenesis

Critical reviews in oncology/hematology, 2022-04, Vol.172, p.103640-103640, Article 103640

2022

Link zum Volltext

Verfügbarkeit prüfen

Multiple Myeloma as a Bone Disease? The Tissue Disruption-Induced Cell Stochasticity (TiDiS) Theory

Cancers, 2020-08, Vol.12 (8), p.2158

2020

Link zum Volltext

Verfügbarkeit prüfen

Noxa up-regulation and mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma

Cancer research (Chicago, Ill.), 2007-06, Vol.67 (11), p.5418-5424

2007

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du Myélome

Journal of clinical oncology, 2008-10, Vol.26 (29), p.4798-4805

2008

Link zum Volltext

Verfügbarkeit prüfen

ABT-737 is highly effective against molecular subgroups of multiple myeloma

Blood, 2011-10, Vol.118 (14), p.3901-3910

2011

Link zum Volltext

Verfügbarkeit prüfen

Toll-like receptors: lessons to learn from normal and malignant human B cells

Blood, 2008-09, Vol.112 (6), p.2205-2213

2008

Link zum Volltext

Verfügbarkeit prüfen

A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines

Haematologica (Roma), 2011-04, Vol.96 (4), p.574-582

2011

Link zum Volltext

Verfügbarkeit prüfen

Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment

Blood, 2001-12, Vol.98 (13), p.3527-3533

2001

Link zum Volltext

Verfügbarkeit prüfen

TLR3 Ligand Induces NF-κB Activation and Various Fates of Multiple Myeloma Cells Depending on IFN-α Production

The Journal of immunology (1950), 2009-04, Vol.182 (7), p.4471-4478

2009

Link zum Volltext

Verfügbarkeit prüfen

Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy

Blood, 2002-09, Vol.100 (5), p.1579-1583

2002

Link zum Volltext

Verfügbarkeit prüfen

Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors

Blood, 2001-11, Vol.98 (10), p.3082-3086

2001

Link zum Volltext

Verfügbarkeit prüfen

Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-xL is an essential survival protein of human myeloma cells

Blood, 2002-07, Vol.100 (1), p.194-199

2002

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-6 is a growth factor for nonmalignant human plasmablasts

Blood, 2001-03, Vol.97 (6), p.1817-1822

2001

Link zum Volltext

Verfügbarkeit prüfen

CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma

Blood, 2003-08, Vol.102 (3), p.1070-1071

2003

Link zum Volltext

Verfügbarkeit prüfen

Chromosome 13 abnormalities identified by FISH analysis and serum β2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy

Blood, 2001-03, Vol.97 (6), p.1566-1571

2001

Link zum Volltext

Verfügbarkeit prüfen

Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation

Blood, 2002-03, Vol.99 (6), p.2185-2191

2002

Link zum Volltext

Verfügbarkeit prüfen

A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

The New England journal of medicine, 1996-07, Vol.335 (2), p.91-97

1996

Link zum Volltext

Verfügbarkeit prüfen

The Ins and Outs of Endosteal Niche Disruption in the Bone Marrow: Relevance for Myeloma Oncogenesis

Biology (Basel, Switzerland), 2023-07, Vol.12 (7), p.990

2023

Link zum Volltext

Verfügbarkeit prüfen

The peripheral CD138+ population but not the CD138− population contains myeloma clonogenic cells in plasma cell leukaemia patients

British journal of haematology, 2012-03, Vol.156 (5), p.679-683

2012

Link zum Volltext

Verfügbarkeit prüfen

Phenotypic characterization of the human myeloma cell growth fraction

Blood, 2005-06, Vol.105 (12), p.4845-4848

2005

Link zum Volltext

Verfügbarkeit prüfen

Multiple Myeloma

The New England journal of medicine, 1997-06, Vol.336 (23), p.1657-1664

1997

Link zum Volltext

Verfügbarkeit prüfen

Multiple Myeloma Exemplifies a Model of Cancer Based on Tissue Disruption as the Initiator Event

Frontiers in oncology, 2018-09, Vol.8, p.355-355

2018

Link zum Volltext

Verfügbarkeit prüfen

Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants

Blood, 2003-02, Vol.101 (4), p.1570-1571

2003

Link zum Volltext

Verfügbarkeit prüfen

Total Soluble HLA Class I and Soluble HLA-G in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance

Clinical cancer research, 2005-10, Vol.11 (20), p.7297-7303

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 302

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(288)
Mit Volltextzugriff
(263)

Publikationsform

Artikel
(301)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(215)
Science & Technology
(193)
Life Sciences & Biomedicine
(191)
Biological And Medical Sciences
(133)
Medical Sciences
(125)
Hematology
(98)
Female
(73)
Immunoglobulinopathies
(73)
Immunopathology
(72)
Immunodeficiencies. Immunoglobulinopathies
(71)
Multiple Myeloma - Pathology
(71)
Male
(68)
Middle Aged
(67)
Aged
(58)
Multiple Myeloma
(56)
Oncology
(56)
Hematologic And Hematopoietic Diseases
(50)
Multiple Myeloma - Genetics
(50)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(48)
Adult
(45)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A bone paradigm challenging the standard model of myeloma oncogenesis

Multiple Myeloma as a Bone Disease? The Tissue Disruption-Induced Cell Stochasticity (TiDiS) Theory

Noxa up-regulation and mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma

Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du Myélome

ABT-737 is highly effective against molecular subgroups of multiple myeloma

Toll-like receptors: lessons to learn from normal and malignant human B cells

A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines

Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment

TLR3 Ligand Induces NF-κB Activation and Various Fates of Multiple Myeloma Cells Depending on IFN-α Production

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome

Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy

Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors

Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-xL is an essential survival protein of human myeloma cells

Interleukin-6 is a growth factor for nonmalignant human plasmablasts

CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma

Chromosome 13 abnormalities identified by FISH analysis and serum β2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy

Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation

A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

The Ins and Outs of Endosteal Niche Disruption in the Bone Marrow: Relevance for Myeloma Oncogenesis

The peripheral CD138+ population but not the CD138− population contains myeloma clonogenic cells in plasma cell leukaemia patients

Phenotypic characterization of the human myeloma cell growth fraction

Multiple Myeloma

Multiple Myeloma Exemplifies a Model of Cancer Based on Tissue Disruption as the Initiator Event

Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants

Total Soluble HLA Class I and Soluble HLA-G in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance

Suchergebnisse filtern